U.S. pharmaceutical research and development, and its impact on women's health the technology deficit in contraception, cancer, and reproductive disease and conditions : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Camden, NJ, May 8, 1992.

U.S. pharmaceutical research and development, and its impact on women's health [electronic resource] : the technology deficit in contraception, cancer, and reproductive disease and conditions : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Camden, NJ, May 8, 1992.

Show other versions (8298)

Saved in:

Bibliographic Details
Online Access:	Full Text (via HeinOnline)
Corporate Author:	United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy (Author)
Other title:	US pharmaceutical research and development, and its impact on women's health. United States pharmaceutical research and development, and its impact on women's health. HeinOnline U.S. Congressional documents. Congressional hearings. HeinOnline women and the law.
Format:	Government Document Electronic eBook
Language:	English
Published:	Washington : U.S. Government Printing Office, 1992.
Subjects:	Women's health services > New Jersey. Women > Health and hygiene > New Jersey. Women's health services > United States. Women > Health and hygiene > United States. Drugs > Research > United States.

Internet

Full Text (via HeinOnline)

Law - Electronic Resources

Holdings details from Law - Electronic Resources
Call Number:	KF27 .S675 1992i
KF27 .S675 1992i (electronic)	Available